Phase I/II study of AT-101 with topotecan in relapsed and refractory small cell lung cancer. [electronic resource]
Producer: 20110203Description: 1637-43 p. digitalISSN:- 1556-1380
- Adenocarcinoma -- drug therapy
- Adult
- Aged
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Cohort Studies
- Drug Resistance, Neoplasm -- drug effects
- Female
- Gossypol -- administration & dosage
- Humans
- Lung Neoplasms -- drug therapy
- Male
- Middle Aged
- Neoplasm Recurrence, Local -- drug therapy
- Neoplasm Staging
- Salvage Therapy
- Small Cell Lung Carcinoma -- drug therapy
- Survival Rate
- Topotecan -- administration & dosage
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Multicenter Study
There are no comments on this title.
Log in to your account to post a comment.